This week, we spotlight the use of the DNA segment, known as CRISPR, for HIV treatment. We also delve into the initial public offering plans of two biotech firms. Additionally, we look at a data-driven approach to precision health and a newly Food and Drug Administration-approved miniature insulin pump. ... READ MORE >
medtech
5 things to know in life sciences: Week of June 19, 2023
This week we spotlight the significant uptick in biotech layoffs in the first quarter as well as the European Commission's strategic postponement of the new Medical Device Regulation. Additionally, we delve into recent groundbreaking approvals encompassing two innovative oral medications for pediatric ... READ MORE >
5 things to know in life sciences: Week of June 12, 2023
This week we're tracking new COVID-19 booster strategies targeting the XBB variant, Moderna's move into mRNA therapies for rare diseases, U. S. Food and Drug Administration guidelines to safeguard tattoo inks, challenges for European medical device startups, and a Scottish startup's pilot telerobot ... READ MORE >
5 things to know in life sciences: Week of June 5, 2023
This week we highlight a shortage of prescription medication in the United States. In addition, we discuss a Food and Drug Administration committee’s recommendation to approve a new RSV vaccine, comments on the Inflation Reduction Act impact, as well as a major acquisition in the diabetes space. Lastly, ... READ MORE >
5 things to know in life sciences: Week of May 22, 2023
This week we look at how artificial intelligence is revolutionizing voice banking for patients with conditions like amyotrophic lateral sclerosis, also known as ALS. In addition, we highlight proposed prescription drug transparency in Medicaid and how the Food and Drug Administration has changed its ... READ MORE >
5 things to know in life sciences: Week of May 1, 2023
This week we look at how the world of digital health is facing an uncertain future when it comes to capital investment. We also examine how researchers have developed a "brain decoder" using neural network technology, gene therapy treatments that offer significant benefits but come with a steep cost, and ... READ MORE >
5 things to know in life sciences: Week of April 24, 2023
This week we look at a World Health Organization meeting on mRNA, using artificial intelligence to streamline clinical trials, Food and Drug Administration approval of a new blood cancer treatment and an upcoming Johnson & Johnson spinout. Finally, we highlight the resumption of a phase 2 trial on an ... READ MORE >
5 things to know in life sciences: Week of April 17, 2023
This week we look at a range of topics in the life sciences industry, from drug pricing negotiations and long-COVID-19 treatment to quantum computing in drug development. Each week we highlight five things affecting the life sciences industry. Here's the latest. Drug pricing negotiation policies are ... READ MORE >
5 things to know in life sciences: Week of April 10, 2023
This week we look at a range of topics in the life sciences industry, from the development of pediatric pacemakers to advancements in health care legislation. We also look at the over $1 billion in venture funds launched last week related to life sciences. Each week we highlight five things affecting ... READ MORE >
5 things to know in life sciences: Week of April 3, 2023
This week we highlight the impact of emerging biopharma on the life sciences industry, a new method for delivering gene therapy, an innovative device to improve safety and sleep quality in infants, and a cutting-edge treatment for vision loss caused by age-related macular degeneration. Finally, we look at ... READ MORE >